Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a challenge for Milestone Pharmaceutical in its 22 years. Now the wait will ...

March 28 (Reuters) - Milestone Pharmaceuticals (MIST.O), opens new tab said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had ...